Immunologic and Hematological Abnormalities in Necrotizing Enterocolitis

Clinics in Perinatology

Volumn 42, Issue 3, 2015, Pages 567-585

  Maheshwari, Akhil ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Blood counts; Inflammation; Macrophages; Monocytes; NEC; Neutrophils; Platelets; Signaling

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; MUCIN 2; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SECRETORY IMMUNOGLOBULIN; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANEMIA; B LYMPHOCYTE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; BASOPHIL; CELLULAR IMMUNITY; CLOSTRIDIA; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DISSEMINATED INTRAVASCULAR CLOTTING; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FIRMICUTES; GAMMAPROTEOBACTERIA; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; INTESTINE INJURY; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; MACROPHAGE; MONOCYTE; NECROTIZING ENTEROCOLITIS; NEUTROPHIL COUNT; NONHUMAN; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; THROMBOCYTE COUNT; BLOOD; COMPLICATION; HEMATOLOGIC DISEASES; IMMUNOLOGY; NEWBORN;

ENTEROCOLITIS, NECROTIZING; HEMATOLOGIC DISEASES; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN;

EID: 84938550940     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2015.04.014     Document Type: Review

References (152)

1. Neu J., Walker W.A. Necrotizing enterocolitis. NEngl J Med 2011, 364:255-264.
2. Maheshwari A., Corbin L.L., Schelonka R.L. Neonatal necrotizing enterocolitis. Res Rep Neonatol 2011, 1:39-53.
3. Patel R.M., Kandefer S., Walsh M.C., et al. Causes and timing of death in extremely premature infants from 2000 through 2011. NEngl J Med 2015, 372:331-340.
4. Maheshwari A., Kelly D.R., Nicola T., et al. TGF-beta(2) suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 2011, 140:242-253.
5. Walsh M.C., Kliegman R.M. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986, 33:179-201.
6. Hsueh W., Caplan M.S., Tan X., et al. Necrotizing enterocolitis of the newborn: pathogenetic concepts in perspective. Pediatr Dev Pathol 1998, 1:2-16.
7. Bury R.G., Tudehope D. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev 2001, (1). CD000405.
8. de la Cochetiere M.F., Piloquet H., des Robert C., et al. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 2004, 56:366-370.
9. Wang Y., Hoenig J.D., Malin K.J., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009, 3:944-954.
10. Maheshwari A., Lacson A., Lu W., et al. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr Res 2004, 56:240-249.
11. Nanthakumar N.N., Young C., Ko J.S., et al. Glucocorticoid responsiveness in developing human intestine: possible role in prevention of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005, 288:G85-G92.
12. Fusunyan R.D., Nanthakumar N.N., Baldeon M.E., et al. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 2001, 49:589-593.
13. Nanthakumar N.N., Fusunyan R.D., Sanderson I., et al. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000, 97:6043-6048.
14. Daig R., Rogler G., Aschenbrenner E., et al. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 2000, 46:350-358.
15. Martin C.R., Walker W.A. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med 2006, 11(5):369-377.
16. Nanthakumar N., Meng D., Goldstein A.M., et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One 2011, 6:e17776.
17. Claud E.C., Lu L., Anton P.M., et al. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 2004, 101:7404-7408.
18. Lotz M., Gütle D., Walther S., et al. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. JExp Med 2006, 203:973-984.
19. Montgomery R.K., Mulberg A.E., Grand R.J. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 1999, 116:702-731.
20. Martin N.A., Mount Patrick S.K., Estrada T.E., et al. Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis. PLoS One 2011, 6:e27191.
21. Mallow E.B., Harris A., Salzman N., et al. Human enteric defensins. Gene structure and developmental expression. JBiol Chem 1996, 271:4038-4045.
22. Zhang C., Sherman M.P., Prince L.S., et al. Paneth cell ablation in the presence of Klebsiella pneumoniae induces necrotizing enterocolitis (NEC)-like injury in the small intestine of immature mice. Dis Model Mech 2012, 5:522-532.
23. MacDonald T.T. Accessory cells in the human gastrointestinal tract. Histopathology 1996, 29:89-92.
24. Rognum T.O., Thrane S., Stoltenberg L., et al. Development of intestinal mucosal immunity in fetal life and the first postnatal months. Pediatr Res 1992, 32:145-149.
25. Braegger C.P., Spencer J., MacDonald T.T. Ontogenetic aspects of the intestinal immune system in man. Int J Clin Lab Res 1992, 22:1-4.
26. Smythies L.E., Sellers M., Clements R.H., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. JClin Invest 2005, 115:66-75.
27. Namachivayam K., Blanco C.L., MohanKumar K., et al. Smad7 inhibits autocrine expression of TGF-beta2 in intestinal epithelial cells in baboon necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2013, 304:G167-G180.
28. Takeda K., Clausen B.E., Kaisho T., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
29. Spencer J., MacDonald T.T., Isaacson P.G. Heterogeneity of non-lymphoid cells expressing HLA-D region antigens in human fetal gut. Clin Exp Immunol 1987, 67:415-424.
30. Wilders M.M., Sminia T., Janse E.M. Ontogeny of non-lymphoid and lymphoid cells in the rat gut with special reference to large mononuclear Ia-positive dendritic cells. Immunology 1983, 50:303-314.
31. Makori N., Tarantal A.F., Lü F.X., et al. Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development. Clin Diagn Lab Immunol 2003, 10:140-153.
32. Emami C.N., Mittal R., Wang L., et al. Recruitment of dendritic cells is responsible for intestinal epithelial damage in the pathogenesis of necrotizing enterocolitis by Cronobacter sakazakii. JImmunol 2011, 186:7067-7079.
33. Finke D., Acha-Orbea H., Mattis A., et al. CD4+CD3- cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 2002, 17:363-373.
34. Spencer J., Finn T., Isaacson P.G. Gut associated lymphoid tissue: a morphological and immunocytochemical study of the human appendix. Gut 1985, 26:672-679.
35. Husband A.J., Gleeson M. Ontogeny of mucosal immunity-environmental and behavioral influences. Brain Behav Immun 1996, 10:188-204.
36. Cornes J.S. Peyer's patches in the human gut. Proc R Soc Med 1965, 58:716.
37. Bhide S.A., Wadekar K.V., Koushik S.A. Peyer's patches are precocious to the appendix in human development. Dev Immunol 2001, 8:159-166.
38. Gebbers J.O., Laissue J.A. Bacterial translocation in the normal human appendix parallels the development of the local immune system. Ann N Y Acad Sci 2004, 1029:337-343.
39. Spencer J., MacDonald T.T., Finn T., et al. The development of gut associated lymphoid tissue in the terminal ileum of fetal human intestine. Clin Exp Immunol 1986, 64:536-543.
40. Latthe M., Terry L., MacDonald T.T. High frequency of CD8 alpha alpha homodimer-bearing T cells in human fetal intestine. Eur J Immunol 1994, 24:1703-1705.
41. Cerf-Bensussan N., Guy-Grand D. Intestinal intraepithelial lymphocytes. Gastroenterol Clin North Am 1991, 20:549-576.
42. Komano H., Fujiura Y., Kawaguchi M., et al. Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 1995, 92:6147-6151.
43. Boismenu R., Havran W.L. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994, 266:1253-1255.
44. Kagnoff M.F. Current concepts in mucosal immunity. III. Ontogeny and function of gamma delta T cells in the intestine. Am J Physiol 1998, 274:G455-G458.
45. Howie D., Spencer J., DeLord D., et al. Extrathymic T cell differentiation in the human intestine early in life. JImmunol 1998, 161:5862-5872.
46. Gunther U., Holloway J.A., Gordon J.N., et al. Phenotypic characterization of CD3-7+ cells in developing human intestine and an analysis of their ability to differentiate into T cells. JImmunol 2005, 174:5414-5422.
47. Spencer J., Isaacson P.G., Walker-Smith J.A., et al. Heterogeneity in intraepithelial lymphocyte subpopulations in fetal and postnatal human small intestine. JPediatr Gastroenterol Nutr 1989, 9:173-177.
48. Fichtelius K.E. The gut epithelium-a first level lymphoid organ?. Exp Cell Res 1968, 49:87-104.
49. Koningsberger J.C., Chott A., Logtenberg T., et al. TCR expression in human fetal intestine and identification of an early T cell receptor beta-chain transcript. JImmunol 1997, 159:1775-1782.
50. Williams A.M., Bland P.W., Phillips A.C., et al. Intestinal alpha beta T cells differentiate and rearrange antigen receptor genes in situ in the human infant. JImmunol 2004, 173:7190-7199.
51. Holtmeier W., Witthoft T., Hennemann A., et al. The TCR-delta repertoire in human intestine undergoes characteristic changes during fetal to adult development. JImmunol 1997, 158:5632-5641.
52. Anttila A., Kauppinen H., Koivusalo A., et al. T-cell-mediated mucosal immunity is attenuated in experimental necrotizing enterocolitis. Pediatr Surg Int 2003, 19:326-330.
53. Pender S.L., Braegger C., Gunther U., et al. Matrix metalloproteinases in necrotising enterocolitis. Pediatr Res 2003, 54:160-164.
54. Mohankumar K., Kaza N., Jagadeeswaran R., et al. Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. Am J Physiol Gastrointest Liver Physiol 2012, 303:G93-G102.
55. Maheshwari A., Schelonka R.L., Dimmitt R.A., et al. Cytokines associated with necrotizing enterocolitis in extremely-low-birth-weight infants. Pediatr Res 2014, 76:100-108.
56. Weitkamp J.H., Rudzinski E., Koyama T., et al. Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria. Pediatr Dev Pathol 2009, 12:443-449.
57. Wildin R.S., Ramsdell F., Peake J., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001, 27:18-20.
58. Silverstein A.M., Lukes R.J. Fetal response to antigenic stimulus. I. Plasmacellular and lymphoid reactions in the human fetus to intrauterine infection. Lab Invest 1962, 11:918-932.
59. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nature reviews. Immunology 2008, 8:523-532.
60. Weitkamp J.H., Koyama T., Rock M.T., et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 2013, 62:73-82.
61. Golby S., Hackett M., Boursier L., et al. Bcell development and proliferation of mature B cells in human fetal intestine. JLeukoc Biol 2002, 72:279-284.
62. Fagarasan S., Kinoshita K., Muramatsu M., et al. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 2001, 413:639-643.
63. Crabbe P.A., Nash D.R., Bazin H., et al. Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest 1970, 22:448-457.
64. Shroff K.E., Meslin K., Cebra J.J. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect Immun 1995, 63:3904-3913.
65. Haworth J.C., Dilling L. Concentration of gamma-A-globulin in serum, saliva, and nasopharyngeal secretions of infants and children. JLab Clin Med 1966, 67:922-933.
66. Brandtzaeg P., Nilssen D.E., Rognum T.O., et al. Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am 1991, 20:397-439.
67. Gleeson M., Cripps A.W., Clancy R.L., et al. Ontogeny of the secretory immune system in man. Aust N Z J Med 1982, 12:255-258.
68. Mellander L., Carlsson B., Hanson L.A. Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood. JPediatr 1984, 104:564-568.
69. Hayes J.A., Adamson-Macedo E.N., Perera S., et al. Detection of secretory immunoglobulin A (SIgA) in saliva of ventilated and non-ventilated preterm neonates. Neuroendocrinol Lett 1999, 20:109-113.
70. Shields C.J., O'Sullivan A.W., Wang J.H., et al. Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation. Ann Surg 2003, 238:249-257.
71. Cripps A.W., Gleeson M., Clancy R.L. Ontogeny of the mucosal immune response in children. Adv Exp Med Biol 1991, 310:87-92.
72. Weemaes C., Klasen I., Göertz J., et al. Development of immunoglobulin A in infancy and childhood. Scand J Immunol 2003, 58:642-648.
73. Fitzsimmons S.P., Evans M.K., Pearce C.L., et al. Immunoglobulin A subclasses in infants' saliva and in saliva and milk from their mothers. JPediatr 1994, 124:566-573.
74. Bhat N.M., Kantor A.B., Bieber M.M., et al. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int Immunol 1992, 4:243-252.
75. Chen Z.J., Wheeler C.J., Shi W., et al. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol 1998, 28:989-994.
76. Bauer K., Zemlin M., Hummel M., et al. Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens. JImmunol 2002, 169:1349-1356.
77. Ogra P.L., Losonsky G.A., Fishaut M. Colostrum-derived immunity and maternal-neonatal interaction. Ann N Y Acad Sci 1983, 409:82-95.
78. Hanson L.A., Korotkova M. The role of breastfeeding in prevention of neonatal infection. Semin Neonatol 2002, 7:275-281.
79. Hanson L.A., Ahlstedt S., Andersson B., et al. The immune response of the mammary gland and its significance for the neonate. Ann Allergy 1984, 53:576-582.
80. Takahashi T., Yoshida Y., Hatano S., et al. Reactivity of secretory IgA antibodies in breast milk from 107 Japanese mothers to 20 environmental antigens. Biol Neonate 2002, 82:238-242.
81. Flamand V., Donckier V., Demoor F.X., et al. CD40 ligation prevents neonatal induction of transplantation tolerance. JImmunol 1998, 160:4666-4669.
82. Araujo E.D., Gonçalves A.K., Cornetta Mda C., et al. Evaluation of the secretory immunoglobulin A levels in the colostrum and milk of mothers of term and pre-term newborns. Braz J Infect Dis 2005, 9:357-362.
83. Caplan M.S., Simon D., Jilling T. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin Pediatr Surg 2005, 14:145-151.
84. Hsueh W., Gonzalez-Crussi F., Arroyave J.L. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Am J Pathol 1986, 122:231-239.
85. Caplan M., Hsueh W., Kelly A., et al. Serum PAF acetylhydrolase increases during neonatal maturation. Prostaglandins 1990, 39:705-714.
86. MacKendrick W., Hill N., Hsueh W., et al. Increase in plasma platelet-activating factor levels in enterally fed preterm infants. Biol Neonate 1993, 64:89-95.
87. Furukawa M., Narahara H., Yasuda K., et al. Presence of platelet-activating factor-acetylhydrolase in milk. JLipid Res 1993, 34:1603-1609.
88. Caplan M.S., Hedlund E., Adler L., et al. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. JPediatr Gastroenterol Nutr 1997, 24:296-301.
89. Ewer A.K., Al-Salti W., Coney A.M., et al. The role of platelet activating factor in a neonatal piglet model of necrotising enterocolitis. Gut 2004, 53:207-213.
90. Caplan M.S., Lickerman M., Adler L., et al. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 1997, 42:779-783.
91. Lu J., Pierce M., Franklin A., et al. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. Pediatr Res 2010, 68:225-230.
92. Wang H., Tan X., Chang H., et al. Regulation of platelet-activating factor receptor gene expression invivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J 1997, 322(Pt 2):603-608.
93. Chokshi N.K., Guner Y.S., Hunter C.J., et al. The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin Perinatol 2008, 32:92-99.
94. Potoka D.A., Upperman J.S., Nadler E.P., et al. NF-kappaB inhibition enhances peroxynitrite-induced enterocyte apoptosis. JSurg Res 2002, 106:7-14.
95. Stanford A., Chen Y., Zhang X.R., et al. Nitric oxide mediates dendritic cell apoptosis by downregulating inhibitors of apoptosis proteins and upregulating effector caspase activity. Surgery 2001, 130:326-332.
96. Ford H., Watkins S., Reblock K., et al. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. JPediatr Surg 1997, 32:275-282.
97. D'Souza A., Fordjour L., Ahmad A., et al. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 2010, 67:526-531.
98. Nadler E.P., Dickinson E., Knisely A., et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. JSurg Res 2000, 92:71-77.
99. Zhou Y., Wang Q., Mark Evers B., et al. Oxidative stress-induced intestinal epithelial cell apoptosis is mediated by p38 MAPK. Biochem Biophys Res Commun 2006, 350:860-865.
100. Baregamian N., Song J., Papaconstantinou J., et al. Intestinal mitochondrial apoptotic signaling is activated during oxidative stress. Pediatr Surg Int 2011, 27:871-877.
101. Clark D.A., Fornabaio D.M., McNeill H., et al. Contribution of oxygen-derived free radicals to experimental necrotizing enterocolitis. Am J Pathol 1988, 130:537-542.
102. Qu X.W., Rozenfeld R.A., Huang W., et al. The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat. Gut 1999, 44:203-211.
103. Chaaban H., Shin M., Sirya E., et al. Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. JPediatr 2010, 157:757-761.
104. Ng P.C., Ang I.L., Chiu R.W., et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. JClin Invest 2010, 120:2989-3000.
105. Edelson M.B., Sonnino R.E., Bagwell C.E., et al. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. JPediatr Surg 1999, 34:1453-1457.
106. Lobe T.E., Richardson C.J., Rassin D.K., et al. Hexosaminidase: a biochemical marker for necrotizing enterocolitis in the preterm infant. Am J Surg 1984, 147:49-52.
107. Bhandari V., Bizzarro M.J., Shetty A., et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006, 117:1901-1906.
108. Viscardi R.M., Lyon N.H., Sun C.C., et al. Inflammatory cytokine mRNAs in surgical specimens of necrotizing enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med 1997, 17:547-559.
109. Caplan M.S., Sun X.M., Hseuh W., et al. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. JPediatr 1990, 116:960-964.
110. Tan X., Hsueh W., Gonzalez-Crussi F. Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. Am J Pathol 1993, 142:1858-1865.
111. Halpern M.D., Holubec H., Dominguez J.A., et al. Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 2002, 51:733-739.
112. Halpern M.D., Khailova L., Molla-Hosseini D., et al. Decreased development of necrotizing enterocolitis in IL-18-deficient mice. Am J Physiol Gastrointest Liver Physiol 2008, 294:G20-G26.
113. Maheshwari A., Christensen R.D., Calhoun D.A., et al. Circulating CXC-chemokine concentrations in a murine intestinal ischemia-reperfusion model. Fetal Pediatr Pathol 2004, 23:145-157.
114. Benkoe T., Reck C., Pones M., et al. Interleukin-8 predicts 60-day mortality in premature infants with necrotizing enterocolitis. JPediatr Surg 2014, 49:385-389.
115. Bhatia A.M., Stoll B.J., Cismowski M.J., et al. Cytokine levels in the preterm infant with neonatal intestinal injury. Am J Perinatol 2014, 31:489-496.
116. Edelson M.B., Bagwell C.E., Rozycki H.J. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999, 103:766-771.
117. Harris M.C., D'Angio C.T., Gallagher P.R., et al. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: correlation with clinical parameters of inflammation and mortality. JPediatr 2005, 147:462-468.
118. Lodha A., Asztalos E., Moore A.M. Cytokine levels in neonatal necrotizing enterocolitis and long-term growth and neurodevelopment. Acta Paediatr 2010, 99:338-343.
119. Kling P.J., Hutter J.J. Hematologic abnormalities in severe neonatal necrotizing enterocolitis: 25 years later. JPerinatol 2003, 23:523-530.
120. O'Neill J.A. Neonatal necrotizing enterocolitis. Surg Clin North Am 1981, 61:1013-1022.
121. Hutter J.J., Hathaway W.E., Wayne E.R. Hematologic abnormalities in severe neonatal necrotizing enterocolitis. JPediatr 1976, 88:1026-1031.
122. Patel C.C. Hematologic abnormalities in acute necrotizing enterocolitis. Pediatr Clin North Am 1977, 24:579-584.
123. Kenton A.B., O'Donovan D., Cass D.L., et al. Severe thrombocytopenia predicts outcome in neonates with necrotizing enterocolitis. JPerinatol 2005, 25:14-20.
124. Ververidis M., Kiely E.M., Spitz L., et al. The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis. JPediatr Surg 2001, 36:799-803.
125. Ragazzi S., Pierro A., Peters M., et al. Early full blood count and severity of disease in neonates with necrotizing enterocolitis. Pediatr Surg Int 2003, 19:376-379.
126. Sola M.C., Del Vecchio A., Rimsza L.M. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clin Perinatol 2000, 27:655-679.
127. Hsueh W., Caplan M.S., Qu X.W., et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003, 6:6-23.
128. Colarizi P., Fiorucci P., Caradonna A., et al. Circulating thrombopoietin levels in neonates with infection. Acta Paediatr 1999, 88:332-337.
129. Oygur N., Tunga M., Mumcu Y., et al. Thrombopoietin levels of thrombocytopenic term and preterm newborns with infection. Am J Perinatol 2001, 18:279-286.
130. Brown R.E., Rimsza L.M., Pastos K., et al. Effects of sepsis on neonatal thrombopoiesis. Pediatr Res 2008, 64:399-404.
131. Sonntag J., Wagner M.H., Waldschmidt J., et al. Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birth weight infants. JPediatr Surg 1998, 33:481-484.
132. Osborn D.A., Lui K., Pussell P., et al. Tand Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness, and effectiveness of testing. Arch Dis Child Fetal Neonatal Ed 1999, 80:F192-F197.
133. Hall N., Ong E.G., Ade-Ajayi N., et al. Tcryptantigen activation is associated with advanced necrotizing enterocolitis. JPediatr Surg 2002, 37:791-793.
134. Boralessa H., Modi N., Cockburn H., et al. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Transfusion 2002, 42:1428-1434.
135. Schutzman D.L., Porat R. Glucose-6-phosphate dehydrogenase deficiency: another risk factor for necrotizing enterocolitis?. JPediatr 2007, 151:435-437.
136. Detlefsen B., Boemers T.M., Schimke C. Necrotizing enterocolitis in premature twins with twin-to-twin transfusion syndrome. Eur J Pediatr Surg 2008, 18:50-52.
137. Singh R., Visintainer P.F., Frantz I.D., et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. JPerinatol 2011, 31:176-182.
138. Szabo J.S., Mayfield S.R., Oh W., et al. Postprandial gastrointestinal blood flow and oxygen consumption: effects of hypoxemia in neonatal piglets. Pediatr Res 1987, 21:93-98.
139. Caplan M.S., Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001, 13:111-115.
140. Reber K.M., Nankervis C.A., Nowicki P.T. Newborn intestinal circulation. Physiology and pathophysiology. Clin Perinatol 2002, 29:23-39.
141. Schober P.H., Nassiri J. Risk factors and severity indices in necrotizing enterocolitis. Acta Paediatr Suppl 1994, 396:49-52.
142. Maheshwari A., Kurundkar A.R., Shaik S.S., et al. Epithelial cells in fetal intestine produce chemerin to recruit macrophages. Am J Physiol Gastrointest Liver Physiol 2009, 297:G1-G10.
143. Smythies L.E., Maheshwari A., Clements R., et al. Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. JLeukoc Biol 2006, 80:492-499.
144. Christensen R.D., Jensen J., Maheshwari A., et al. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63 000 records in a multihospital health-care system. JPerinatol 2010, 30:540-545.
145. van Furth R., Sluiter W. Distribution of blood monocytes between a marginating and a circulating pool. JExp Med 1986, 163:474-479.
146. Remon J., Kampanatkosol R., Kaul R.R., et al. Acute drop in blood monocyte count differentiates NEC from other causes of feeding intolerance. JPerinatol 2014, 34:549-554.
147. Christensen R.D., Lambert D.K., Gordon P.V., et al. Neonates presenting with bloody stools and eosinophilia can progress to two different types of necrotizing enterocolitis. JPerinatol 2012, 32(11):874-879.
148. Kim D.-H., Bae S.-P., Hahn W.-H., et al. Low basophil count and red cell distribution width at birth may predict the development of neonatal necrotizing enterocolitis: a matched control study. Soonchunhyang Med Sci 2013, 19:61-64.
149. Hill D.A., Siracusa M.C., Abt M.C., et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 2012, 18:538-546.
150. Lambert D.K., Christensen R.D., Baer V.L., et al. Fulminant necrotizing enterocolitis in a multihospital healthcare system. JPerinatol 2012, 32:194-198.
151. Mandel D., Lubetzky R., Mimouni F.B., et al. Nucleated red blood cells in preterm infants who have necrotizing enterocolitis. JPediatr 2004, 144:653-655.
152. Baschat A.A., Gungor S., Kush M.L., et al. Nucleated red blood cell counts in the first week of life: a critical appraisal of relationships with perinatal outcome in preterm growth-restricted neonates. Am J Obstet Gynecol 2007, 197:286.e1-286.e8.